Neogen (FRA:NG2) Other Current Assets: €111.1 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NG2 Neogen Corp FRA:NG2
69 GF Score
Price €8.88
GF Value €10.62
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Neogen Other Current Assets?

Neogen FRA:NG2 +3.67% 69 Other Current Assets is €111.1 Mil as of Feb. 2026. GuruFocus rates FRA:NG2 with a GF Score™ of 69/100 and a GF Value™ of €10.62 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Neogen's other current assets for the quarter that ended in Feb. 2026 was €111.1 Mil.

Neogen's quarterly other current assets increased from Aug. 2025 (€45.8 Mil) to Nov. 2025 (€116.3 Mil) but then declined from Nov. 2025 (€116.3 Mil) to Feb. 2026 (€111.1Mil).

Neogen's annual other current assets increased from May. 2023 (€49.0 Mil) to May. 2024 (€51.8 Mil) increased from May. 2024 (€51.8 Mil) to May. 2025 (€92.0 Mil).


Neogen Other Current Assets Related Terms


Neogen Other Current Assets Historical Data

* Premium members only.

The historical data trend for Neogen's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Other Current Assets Chart

Neogen Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.68 22.48 49.03 51.82 91.97

Neogen Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.16 91.97 45.79 116.32 111.08
FRA:NG2
69GF Score
Neogen Corp FRA:NG2
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neogen Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of €111.1 Mil mean?
Neogen (FRA:NG2) has a Other Current Assets of €111.1 Mil as of Feb. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Neogen.
Is Neogen's Other Current Assets too high?
Neogen's current Other Current Assets is €111.1 Mil. Overall, Neogen has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neogen's Other Current Assets compare to UFPT and ALMR?
Neogen's Other Current Assets of €111.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Devices & Instruments company?
A good Other Current Assets depends on the Medical Devices & Instruments industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Neogen. Neogen's current Other Current Assets is €111.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Modestly Undervalued. The stock's GF Value™ is €10.62, compared to a current price of €8.88 — trading 16.4% below its estimated fair value. The current Other Current Assets is €111.1 Mil. Neogen's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Neogen (FRA:NG2), the current Other Current Assets is €111.1 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be undervalued. The current stock price of €8.88 is trading 16.4% below its estimated GF Value™ of €10.62. GuruFocus considers Neogen to be Modestly Undervalued.

Key valuation signals for FRA:NG2:

  • Other Current Assets: €111.1 Mil
  • GF Value™: €10.62 vs. price of €8.88 (16.4% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
69GF Score

Get the complete analysis for FRA:NG2

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.88
Price
€10.62
GF Value